AbbVie (ABBV) FCF Margin (2012 - 2026)

AbbVie (ABBV) has reported FCF Margin for 15 consecutive years, with 18.33% the latest figure, recorded in Q2 2026.

• On a quarterly basis, FCF Margin fell 1334.0% year-over-year to 18.33% in Q2 2026; TTM through Jun 2026 was 28.28%, a 299.0% decrease from a year earlier, with the FY2025 full-year figure at 29.13%, down 252.0% from the prior year.
• FCF Margin was 18.33% for Q2 2026 at AbbVie, down from 23.76% in the prior quarter.
• Over five years, FCF Margin peaked at 52.81% in Q3 2023 and troughed at 10.49% in Q1 2025.
• A 5-year average of 33.88% and a median of 33.1% in 2022 frame the typical range for FCF Margin.
• Across the five-year window, FCF Margin sank 3025 bps in 2024 and jumped 1763 bps in 2025, its largest moves.
• Over 5 years, FCF Margin stood at 47.72% in 2022, then plunged by 33 bps to 31.8% in 2023, then soared by 41 bps to 44.74% in 2024, then sank by 34 bps to 29.42% in 2025, then sank by 38 bps to 18.33% in 2026.
• The last three FCF Margin figures came in at 18.33% (Q2 2026), 23.76% (Q1 2026), and 29.42% (Q4 2025), per Business Quant data.